九典制药：签署小分子镇痛药物专利及技术转让协议

Core Viewpoint - The company Jiutian Pharmaceutical (300705) plans to sign a patent and technology transfer agreement with Suzhou Yuanju Pharmaceutical Technology Co., Ltd. for the small molecule analgesic drug YJ2301 project, with a total transfer fee not exceeding 400 million yuan [1] Group 1 - The agreement aims to introduce advanced technology and patents in the small molecule analgesic field, which will further supplement and enhance the company's existing R&D pipeline [1]